AB Science S.A. (0Q77.L)
EUR 0.87
(-6.75%)
EUR 0.87
(-6.75%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.20 EUR | 31.03% |
| 2022 | -0.29 EUR | 3.33% |
| 2021 | -0.30 EUR | 11.76% |
| 2020 | -0.34 EUR | 38.18% |
| 2019 | -0.55 EUR | 20.29% |
| 2018 | -0.69 EUR | 8.0% |
| 2017 | -0.75 EUR | 3.85% |
| 2016 | -0.78 EUR | 0.0% |
| 2015 | -0.78 EUR | -59.18% |
| 2014 | -0.49 EUR | -8.89% |
| 2013 | -0.45 EUR | -32.35% |
| 2012 | -0.34 EUR | -9.68% |
| 2011 | -0.31 EUR | 3.13% |
| 2010 | -0.32 EUR | -14.29% |
| 2009 | -0.28 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.09 EUR | 0.0% |
| 2023 Q3 | -0.02 EUR | 93.09% |
| 2023 Q4 | -0.02 EUR | 0.0% |
| 2023 FY | - EUR | 31.03% |
| 2023 Q1 | -0.11 EUR | 21.43% |
| 2023 Q2 | -0.22 EUR | -100.0% |
| 2022 Q3 | -0.07 EUR | 53.33% |
| 2022 Q2 | -0.15 EUR | -97.89% |
| 2022 Q1 | -0.08 EUR | 63.9% |
| 2022 FY | - EUR | 3.33% |
| 2022 Q4 | -0.14 EUR | -100.0% |
| 2021 Q2 | -0.10 EUR | -98.8% |
| 2021 Q1 | -0.05 EUR | 64.29% |
| 2021 FY | - EUR | 11.76% |
| 2021 Q4 | -0.21 EUR | -110.0% |
| 2021 Q3 | -0.10 EUR | -0.6% |
| 2020 Q2 | -0.23 EUR | -91.67% |
| 2020 Q3 | -0.06 EUR | 72.61% |
| 2020 FY | - EUR | 38.18% |
| 2020 Q1 | -0.12 EUR | 42.86% |
| 2020 Q4 | -0.14 EUR | -122.22% |
| 2019 Q2 | -0.34 EUR | -100.0% |
| 2019 FY | - EUR | 20.29% |
| 2019 Q1 | -0.17 EUR | 15.0% |
| 2019 Q4 | -0.21 EUR | -90.91% |
| 2019 Q3 | -0.11 EUR | 67.65% |
| 2018 Q2 | -0.15 EUR | 0.0% |
| 2018 Q1 | -0.15 EUR | 21.05% |
| 2018 FY | - EUR | 8.0% |
| 2018 Q4 | -0.20 EUR | 0.0% |
| 2018 Q3 | -0.20 EUR | -33.33% |
| 2017 FY | - EUR | 3.85% |
| 2017 Q4 | -0.19 EUR | 0.0% |
| 2017 Q1 | -0.19 EUR | -5.56% |
| 2017 Q2 | -0.19 EUR | 0.0% |
| 2017 Q3 | -0.19 EUR | 0.0% |
| 2016 Q4 | -0.18 EUR | 0.0% |
| 2016 Q3 | -0.18 EUR | 14.29% |
| 2016 Q1 | -0.21 EUR | -5.0% |
| 2016 FY | - EUR | 0.0% |
| 2016 Q2 | -0.21 EUR | 0.0% |
| 2015 FY | - EUR | -59.18% |
| 2015 Q2 | -0.20 EUR | -5.26% |
| 2015 Q4 | -0.20 EUR | 0.0% |
| 2015 Q3 | -0.20 EUR | 0.0% |
| 2015 Q1 | -0.19 EUR | -35.71% |
| 2014 Q4 | -0.14 EUR | 0.0% |
| 2014 FY | - EUR | -8.89% |
| 2014 Q1 | -0.11 EUR | 8.33% |
| 2014 Q2 | -0.11 EUR | 0.0% |
| 2014 Q3 | -0.14 EUR | -27.27% |
| 2013 Q2 | -0.10 EUR | -1.73% |
| 2013 Q3 | -0.12 EUR | -20.0% |
| 2013 Q4 | -0.12 EUR | 0.0% |
| 2013 FY | - EUR | -32.35% |
| 2013 Q1 | -0.10 EUR | 0.0% |
| 2012 FY | - EUR | -9.68% |
| 2011 FY | - EUR | 3.13% |
| 2010 FY | - EUR | -14.29% |
| 2009 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Boiron SA | 2.06 EUR | 109.709% |
| Laboratorios Farmaceuticos Rovi, S.A. | 3.20 EUR | 106.25% |
| Vetoquinol SA | 4.70 EUR | 104.255% |
| Valneva SE | -0.73 EUR | 72.603% |
| Nanobiotix S.A. | -1.08 EUR | 81.481% |
| PHAXIAM Therapeutics S.A. | -5.00 EUR | 96.0% |
| Vivoryon Therapeutics N.V. | -1.12 EUR | 82.143% |
| BioSenic S.A. | -0.21 EUR | 4.762% |
| ABIVAX Société Anonyme | -3.43 EUR | 94.169% |
| Formycon AG | 4.76 EUR | 104.202% |